MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2018 International Congress

    Ondansetron, a highly-selective 5-HT3 receptor antagonist, alleviates L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson’s disease

    C. Kwan, I. Frouni, D. Bédard, A. Hamadjida, P. Huot (Montreal, QC, Canada)

    Objective: To determine the effectiveness of selective serotonin 3 (5-HT3) receptor blockade at reducing the severity of established, and preventing the development of, dyskinesia. Background:…
  • 2018 International Congress

    Impact of Age on Levodopa dosage regimes in Idiopathic Parkinson’s Disease

    L. Scourfield, S. Sultana, C. Thomas, B. Mohamed (Cardiff, United Kingdom)

    Objective: To assess the influence of patient age on prescribed dosage and subsequent dose escalation regimes of levodopa therapy in a cohort of people with…
  • 2018 International Congress

    Eye Movement Abnormalities Correspond to Pontine Atrophy in Wilson Disease

    J. Hanuška, P. Dušek, J. Rusz, O. Ulmanová, A. Burgetová, E. Růžička (Prague, Czech Republic)

    Objective: This study aims to characterize eye movement (EM) abnormalities in Wilson´s disease (WD) and to assess their relation to clinical severity of WD and…
  • 2018 International Congress

    Comparative results between preoperative acute levodopa challenge test and deep brain stimulation

    D. Fitas, M.J. Rosas, J. Parada Lima, C. Reis, P. Linhares, R. Vaz (Viana do Castelo, Portugal)

    Objective: Our aim is to compare motor clinical benefits after acute levodopa challenge test, with those obtained further with deep brain stimulation (DBS). Background: DBS…
  • 2018 International Congress

    Practice patterns, motor outcomes and health disparities in patients undergoing Deep Brain Stimulation for Parkinson’s disease

    C. Luca, D. Garbin diLuca, H. Moore, C. Singer, I. Cajigas, J. Jagid (Miami, FL, USA)

    Objective: To describe the DBS practice patterns at University of Miami Movement Disorder Center, motor outcomes and health disparities among ethnic groups. Background: Deep brain…
  • 2018 International Congress

    Prevelance in the World

    Tur. Djakhangir (Tashkent, Uzbekistan)

    Objective: To analyze the static data in the incidence of Parkinson disease in the world. Background: Parkinson’s disease is considered a progressive multisystem disorder involving…
  • 2018 International Congress

    Parkinsonism with rare sequence variants in VPS35 and FBXO7 genes associated with Lewy body pathology

    K. Mensikova, L. Tuckova, R. Vodicka, K. Kolarikova, T. Bartonikova, J. Ehrmann, R. Vrtel, P. Kanovsky (Olomouc, Czech Republic)

    Objective: To detect a neuropathological background of parkinsonism associated with rare sequence variants in the VPS35 and FBXO7 genes. Background: A total of 23 gene…
  • 2018 International Congress

    Visual impairment and falls in Parkinson’s disease (PD)

    N. Butt, M. Khwaja, A. Chatterjee (Reading, United Kingdom)

    Objective: To review prevalence of visual impairment and falls in patients with Parkinson’s disease. Background: Falls are common and multifactorial in origin in patients with…
  • 2018 International Congress

    MSA Preliminary Panamerican Report

    M. Cesarini, E. Gatto, J. Etcheverry, G. Da Prat, N. Gonzalez Rojas, H. Teive, M. Rodriguez, J. Ziliani, M. Miranda, P. Chana, F. Cardoso, A. Cardozo, C. Uribe Roca, I. Amorin, L. Abaroa, c. Cosentino, Y. Nuñez, A. Lescano, E. Dieguez, A. Alleva, I. Litvan, G. Wenning (La Plata, Argentina)

    Objective: To report the results of the PAN American MSA (PANMSA) database Background: Multiple system atrophy (MSA) is a rare neurodegenerative disease and coordinated efforts…
  • 2018 International Congress

    Corticobasal Syndrome: A Single Center Case Series

    M. Siddiqui, C. Goas (Winston Salem, NC, USA)

    Objective: To evaluate clinical features of corticobasal syndrome in a tertiary care setting. Background: None. Methods: A retrospective chart review was done. All patients diagnosed…
  • « Previous Page
  • 1
  • …
  • 205
  • 206
  • 207
  • 208
  • 209
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Carpal Tunnel Syndrome in Patients with Tremor
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley